These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35505336)

  • 21. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal Fluid Characterization in Cynomolgus Monkeys, Beagle Dogs, and Göttingen Minipigs.
    Ballesteros C; Pouliot M; Froment R; Maghezzi MS; St-Jean C; Li C; Paquette D; Authier S
    Int J Toxicol; 2020; 39(2):124-130. PubMed ID: 32066300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice.
    Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM
    Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
    Sinclair AJ; Wienholt L; Tantsis E; Brilot F; Dale RC
    Dev Med Child Neurol; 2013 Jan; 55(1):71-5. PubMed ID: 23095051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.
    Thorne RG; Frey WH
    Clin Pharmacokinet; 2001; 40(12):907-46. PubMed ID: 11735609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic daily intrathecal injections of a large volume of fluid increase mast cells in the thalamus of mice.
    Taiwo OB; Kovács KJ; Larson AA
    Brain Res; 2005 Sep; 1056(1):76-84. PubMed ID: 16098954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
    Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
    Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.
    Calias P; Banks WA; Begley D; Scarpa M; Dickson P
    Pharmacol Ther; 2014 Nov; 144(2):114-22. PubMed ID: 24854599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intrathecal administration of drugs].
    Lebedev IA; Levitina EV; Akimzhanova AK; Rakhmanina OA; Shtork TE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):89-92. PubMed ID: 28635861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal Access Through Suboccipital Port in Patients With Spinal Muscular Atrophy and Complex Spines: Case Series and Technical Note.
    Tran DK; Shah V; Muhonen MG
    Cureus; 2020 Aug; 12(8):e9525. PubMed ID: 32905153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice.
    Householder KT; Dharmaraj S; Sandberg DI; Wechsler-Reya RJ; Sirianni RW
    Sci Rep; 2019 Aug; 9(1):12587. PubMed ID: 31467368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
    Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained intrathecal therapeutic protein delivery using genetically transduced tissue implants in a freely moving rat model.
    Aronson JP; Katnani HA; Pomerantseva I; Shapir N; Tse H; Miari R; Goltsman H; Mwizerwa O; Neville CM; Neil GA; Eskandar EN; Sundback CA
    Int J Pharm; 2017 Dec; 534(1-2):42-49. PubMed ID: 28986320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells.
    Oshiro EM; Viola JJ; Oldfield EH; Walbridge S; Bacher J; Frank JA; Blaese RM; Ram Z
    Cancer Gene Ther; 1995 Jun; 2(2):87-95. PubMed ID: 7621261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression along the cerebral-spinal axis after regional gene delivery.
    Meuli-Simmen C; Liu Y; Yeo TT; Liggitt D; Tu G; Yang T; Meuli M; Knauer S; Heath TD; Longo FM; Debs RJ
    Hum Gene Ther; 1999 Nov; 10(16):2689-700. PubMed ID: 10566897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direction and magnitude of cerebrospinal fluid flow vary substantially across central nervous system diseases.
    Eide PK; Valnes LM; Lindstrøm EK; Mardal KA; Ringstad G
    Fluids Barriers CNS; 2021 Apr; 18(1):16. PubMed ID: 33794929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The frequency and magnitude of cerebrospinal fluid pulsations influence intrathecal drug distribution: key factors for interpatient variability.
    Hsu Y; Hettiarachchi HD; Zhu DC; Linninger AA
    Anesth Analg; 2012 Aug; 115(2):386-94. PubMed ID: 22523420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonuniform Moving Boundary Method for Computational Fluid Dynamics Simulation of Intrathecal Cerebrospinal Flow Distribution in a Cynomolgus Monkey.
    Khani M; Xing T; Gibbs C; Oshinski JN; Stewart GR; Zeller JR; Martin BA
    J Biomech Eng; 2017 Aug; 139(8):0810051-08100512. PubMed ID: 28462417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.